PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Hydrocortisone Aceponate→

Hydrocortisone Aceponate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
74050-20-7
Molecular formula
C26H36O7
Molecular weight
460.6 g/mol
Drug class
Topical dermocorticosteroidpotent glucocorticoid
Mechanism of action
A lipophilic glucocorticoid diester with local glucocorticoid activity in the skin. Activation of glucocorticoid receptors suppresses inflammatory and pruritic responses.
Indications / reported uses
  • Topical treatment of inflammatory and pruritic dermatoses in dogs, under the veterinary product authorisation.

Sources: https://ec.europa.eu/health/documents/community-register/2019/20190513144814/anx_144814_en.pdf · https://www2.zoetis.com.au/content/_assets/docs/Resource-center/AVDAP-Guidelines.pdf

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Hydrocortisone Aceponate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Hydrocortisone Aceponate Permitted Daily Exposure (PDE) report (the Hydrocortisone Aceponate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Hydrocortisone Aceponate Occupational Exposure Limit (OEL) report (the Hydrocortisone Aceponate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.